GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Other Net Income (Loss)

Optimind Pharma (XCNQ:OMND) Other Net Income (Loss) : C$-0.00 Mil (TTM As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Other Net Income (Loss)?

Optimind Pharma's Other Net Income (Loss) for the three months ended in Nov. 2023 was C$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.00 Mil.

Optimind Pharma's annual Other Net Income (Loss) stayed the same from . 20 (C$0.00 Mil) to Feb. 2022 (C$0.00 Mil) but then increased from Feb. 2022 (C$0.00 Mil) to Feb. 2023 (C$0.00 Mil).

Optimind Pharma Other Net Income (Loss) Historical Data

The historical data trend for Optimind Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Other Net Income (Loss) Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Other Net Income (Loss)
- -

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Other Net Income (Loss) Get a 7-Day Free Trial - - - - -

Optimind Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimind Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Other Net Income (Loss)
Comparable Companies
XCNQ:NLV TSXV:GENX XCNQ:AYUR XCNQ:PHRX XCNQ:J XCNQ:CRCC XCNQ:BCBC XCNQ:CVGR XCNQ:PBF TSXV:HMPG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Website
https://www.optimindpharma.com
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines